Skip to main content
Top
Published in: Journal of Nanoparticle Research 1/2013

01-01-2013 | Research Paper

Engineering of magnetic DNA nanoparticles for tumor-targeted therapy

Authors: Hossein Hosseinkhani, Yi-Ru Chen, Wenjie He, Po-Da Hong, Dah-Shyong Yu, Abraham J. Domb

Published in: Journal of Nanoparticle Research | Issue 1/2013

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

This study aims to engineer novel targeted delivery system composed of magnetic DNA nanoparticles to be effective as an efficient targeted gene therapy vehicle for tumor therapy. A polysaccharide, dextran, was chosen as the vector of plasmid DNA-encoded NK4 that acts as an HGF-antagonist and anti-angiogenic regulator for inhibitions of tumor growth, invasion, and metastasis. Spermine (Sm) was chemically introduced to the hydroxyl groups of dextran to obtain dextran-Sm. When Fe2+ solution was added to the mixture of dextran-Sm and a plasmid DNA, homogenous DNA nanoparticles were formed via chemical metal coordination bonding with average size of 230 nm. Characterization of DNA nanoparticles was performed via dynamic light scattering measurement, electrophoretic light scattering measurement, as well as transmission electron microscope. DNA nanoparticles effectively condensed plasmid DNA into nanoparticles and enhanced the stability of DNA, while significantly improved transfection efficiency in vitro and tumor accumulation in vivo. In addition, magnetic DNA nanoparticles exhibited high efficiency in antitumor therapy with regards to tumor growth as well as survival of animals evaluated in the presence of external magnetic field. We conclude that the magnetic properties of these DNA nanoparticles would enhance the tracking of non-viral gene delivery systems when administrated in vivo in a test model. These findings suggest that DNA nanoparticles effectively deliver DNA to tumor and thereby inhibiting tumor growth.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
go back to reference Abdullah S, Yeo Y, Hosseinkhani H, Hosseinkhani M, Masrawa E, Ramasamy R, Rosli R, Rahman SA, Domb AJ (2010) Gene transfer into the lung by nanoparticles dextran-spermine/plasmid DNA complexes. J Biomed Biotechnol 2010:1–10CrossRef Abdullah S, Yeo Y, Hosseinkhani H, Hosseinkhani M, Masrawa E, Ramasamy R, Rosli R, Rahman SA, Domb AJ (2010) Gene transfer into the lung by nanoparticles dextran-spermine/plasmid DNA complexes. J Biomed Biotechnol 2010:1–10CrossRef
go back to reference Abedini F, Ismail M, Hosseinkhani H, Azmi TI, Omar AR, Chong PP et al (2010) Toxicity evaluation of dextran-spermine polycation as a tool for gene therapy in vitro. J Cell Anim Biol 4:170–176 Abedini F, Ismail M, Hosseinkhani H, Azmi TI, Omar AR, Chong PP et al (2010) Toxicity evaluation of dextran-spermine polycation as a tool for gene therapy in vitro. J Cell Anim Biol 4:170–176
go back to reference Abedini F, Hosseinkhani H, Ismail M, Omar AR, Chong PP, Domb AJ (2011a) In vitro intracellular trafficking of biodegradable nanoparticles of dextran-spermine in cancer cell lines. Int J Nanotechnol 8:712–723CrossRef Abedini F, Hosseinkhani H, Ismail M, Omar AR, Chong PP, Domb AJ (2011a) In vitro intracellular trafficking of biodegradable nanoparticles of dextran-spermine in cancer cell lines. Int J Nanotechnol 8:712–723CrossRef
go back to reference Abedini F, Ismail M, Hosseinkhani H, Azmi TI, Omar AR, Pei Pei C, Bejo MH, Domb AJ (2011b) Effects of CXCR4 siRNAs/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver. Cancer Manag Res 3:301–309 Abedini F, Ismail M, Hosseinkhani H, Azmi TI, Omar AR, Pei Pei C, Bejo MH, Domb AJ (2011b) Effects of CXCR4 siRNAs/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver. Cancer Manag Res 3:301–309
go back to reference Azzam T, Eliyahu H, Shapira L, Linial M, Barenholz Y, Domb AJ (2002) Polysaccharide-oligo amine based conjugates for gene delivery. J Med Chem 45:1817–1823CrossRef Azzam T, Eliyahu H, Shapira L, Linial M, Barenholz Y, Domb AJ (2002) Polysaccharide-oligo amine based conjugates for gene delivery. J Med Chem 45:1817–1823CrossRef
go back to reference Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364CrossRef Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364CrossRef
go back to reference Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214–221CrossRef Harris JM, Chess RB (2003) Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2:214–221CrossRef
go back to reference Holmgren L, O’Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149–153CrossRef Holmgren L, O’Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149–153CrossRef
go back to reference Hosseinkhani H (2006) DNA nanoparticles for gene delivery to cells and tissue. Int J Nanotechnol 3:416–461CrossRef Hosseinkhani H (2006) DNA nanoparticles for gene delivery to cells and tissue. Int J Nanotechnol 3:416–461CrossRef
go back to reference Hosseinkhani H, Hosseinkhani M (2009) Biodegradable polymer-metal complexes for gene and drug delivery. Curr Drug Saf 4:79–83CrossRef Hosseinkhani H, Hosseinkhani M (2009) Biodegradable polymer-metal complexes for gene and drug delivery. Curr Drug Saf 4:79–83CrossRef
go back to reference Hosseinkhani H, Tabata Y (2005) Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran. J Control Release 108:540–556CrossRef Hosseinkhani H, Tabata Y (2005) Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran. J Control Release 108:540–556CrossRef
go back to reference Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2002) Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination. J Control Release 83:286–301CrossRef Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2002) Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination. J Control Release 83:286–301CrossRef
go back to reference Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2003) Tumor targeting of gene expression by dextran conjugation based on metal coordination. J Control Release 88:297–312CrossRef Hosseinkhani H, Aoyama T, Ogawa O, Tabata Y (2003) Tumor targeting of gene expression by dextran conjugation based on metal coordination. J Control Release 88:297–312CrossRef
go back to reference Hosseinkhani H, Azzam T, Tabata Y, Domb AJ (2004) Dextran-spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection. Gene Ther 11:194–203CrossRef Hosseinkhani H, Azzam T, Tabata Y, Domb AJ (2004) Dextran-spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection. Gene Ther 11:194–203CrossRef
go back to reference Hosseinkhani H, Azzam T, Kobayashi H, Hiraoka Y, Shimokawa H, Domb AJ, Tabata Y (2006a) Combination of 3-D tissue engineered scaffold and non-viral gene enhance in vitro DNA expression of mesenchymal stem cells. Biomaterials 27:269–4278 Hosseinkhani H, Azzam T, Kobayashi H, Hiraoka Y, Shimokawa H, Domb AJ, Tabata Y (2006a) Combination of 3-D tissue engineered scaffold and non-viral gene enhance in vitro DNA expression of mesenchymal stem cells. Biomaterials 27:269–4278
go back to reference Hosseinkhani H, Kushibiki T, Matsumoto K, Nakamura T, Tabata Y (2006b) Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound. Cancer Gene Ther 13:479–489CrossRef Hosseinkhani H, Kushibiki T, Matsumoto K, Nakamura T, Tabata Y (2006b) Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound. Cancer Gene Ther 13:479–489CrossRef
go back to reference Hosseinkhani H, Hosseinkhani M, Khademhosseini (2006c) A Emerging applications of hydrogels and microscale technologies in drug discovery. Drug Discov 1:32–34 Hosseinkhani H, Hosseinkhani M, Khademhosseini (2006c) A Emerging applications of hydrogels and microscale technologies in drug discovery. Drug Discov 1:32–34
go back to reference Hosseinkhani M, Hosseinkhani H, Chen YR, Subramani K (2011a) In vitro physicochemical evaluation of DNA nanoparticles. Int J Nanotechnol 8:736–748CrossRef Hosseinkhani M, Hosseinkhani H, Chen YR, Subramani K (2011a) In vitro physicochemical evaluation of DNA nanoparticles. Int J Nanotechnol 8:736–748CrossRef
go back to reference Hosseinkhani H, Hosseinkhani M, Chen YR, Subramani K, Domb AJ (2011b) Innovative technology of engineering magnetic DNA nanoparticles for gene therapy. Int J Nanotechnol 8:724–735CrossRef Hosseinkhani H, Hosseinkhani M, Chen YR, Subramani K, Domb AJ (2011b) Innovative technology of engineering magnetic DNA nanoparticles for gene therapy. Int J Nanotechnol 8:724–735CrossRef
go back to reference Kircheis R, Wightman L, Schreiber A, Robitza B, Rossler V, Kursa M, Wagner (2001) Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 8:28–40CrossRef Kircheis R, Wightman L, Schreiber A, Robitza B, Rossler V, Kursa M, Wagner (2001) Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 8:28–40CrossRef
go back to reference Kuba K, Matsumoto K, Ohnishi K, Shiratsuchi T, Tanaka M, Nakamura T (2000a) Kringle 1–4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells. Biochem Biophys Res Commun 279:846–852CrossRef Kuba K, Matsumoto K, Ohnishi K, Shiratsuchi T, Tanaka M, Nakamura T (2000a) Kringle 1–4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells. Biochem Biophys Res Commun 279:846–852CrossRef
go back to reference Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T (2000b) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 60:6737–6743 Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M, Nakamura T (2000b) HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 60:6737–6743
go back to reference Kushibiki T, Matsumoto K, Nakamura T, Tabata Y (2004) Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther 11:1205–1214CrossRef Kushibiki T, Matsumoto K, Nakamura T, Tabata Y (2004) Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther 11:1205–1214CrossRef
go back to reference Langer R, Tirrell DA (2004) Designing materials for biology and medicine. Nature 428:487–492CrossRef Langer R, Tirrell DA (2004) Designing materials for biology and medicine. Nature 428:487–492CrossRef
go back to reference Maemondo M, Narumi K, Saijo Y et al (2002) Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy. Mol Ther 5:177–185CrossRef Maemondo M, Narumi K, Saijo Y et al (2002) Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy. Mol Ther 5:177–185CrossRef
go back to reference Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, Journeay WS et al (2011) Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev 111:253–280CrossRef Mahmoudi M, Hosseinkhani H, Hosseinkhani M, Boutry S, Simchi A, Journeay WS et al (2011) Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev 111:253–280CrossRef
go back to reference Molineux G (2003) Pegylation: engineering improved biopharmaceuticals for oncology. Pharmacotherapy 23:3S–8SCrossRef Molineux G (2003) Pegylation: engineering improved biopharmaceuticals for oncology. Pharmacotherapy 23:3S–8SCrossRef
go back to reference O’Reilly MS, Holmgren L, Chen C, Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2:689–692CrossRef O’Reilly MS, Holmgren L, Chen C, Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2:689–692CrossRef
go back to reference Peppas NA, Langer R (1994) New challenges in biomaterials. Science 263:1715–1720CrossRef Peppas NA, Langer R (1994) New challenges in biomaterials. Science 263:1715–1720CrossRef
go back to reference Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54:459–476CrossRef Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54:459–476CrossRef
go back to reference Saimura M, Nagai E, Mizumoto K et al (2002) Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Cancer Gene Ther 9:799–806CrossRef Saimura M, Nagai E, Mizumoto K et al (2002) Intraperitoneal injection of adenovirus-mediated NK4 gene suppresses peritoneal dissemination of pancreatic cancer cell line AsPC-1 in nude mice. Cancer Gene Ther 9:799–806CrossRef
go back to reference Sato N, Kobayashi H, Saga T, Nakamoto Y, Ishimori T, Togashi K et al (2001) Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin Cancer Res 7:3606–3612 Sato N, Kobayashi H, Saga T, Nakamoto Y, Ishimori T, Togashi K et al (2001) Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice. Clin Cancer Res 7:3606–3612
go back to reference Sim BK, MacDonald NJ, Gubish ER (2000) Angiostatin and endostatin: endogenous inhibitors of tumor growth. Cancer Metastasis Rev 19:181–190CrossRef Sim BK, MacDonald NJ, Gubish ER (2000) Angiostatin and endostatin: endogenous inhibitors of tumor growth. Cancer Metastasis Rev 19:181–190CrossRef
Metadata
Title
Engineering of magnetic DNA nanoparticles for tumor-targeted therapy
Authors
Hossein Hosseinkhani
Yi-Ru Chen
Wenjie He
Po-Da Hong
Dah-Shyong Yu
Abraham J. Domb
Publication date
01-01-2013
Publisher
Springer Netherlands
Published in
Journal of Nanoparticle Research / Issue 1/2013
Print ISSN: 1388-0764
Electronic ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-012-1345-z

Other articles of this Issue 1/2013

Journal of Nanoparticle Research 1/2013 Go to the issue

Premium Partners